Inhibition of InhA, the Enoyl Reductase from Mycobacterium tuberculosis, by Triclosan and Isoniazid
Authors:
- 8 June 2000
- journal article
- Published by American Chemical Society (ACS) in Biochemistry
- Vol. 39 (26) , 7645-7650
Abstract
Structural and genetic studies indicate that the antibacterial compound triclosan, an additive in many personal care products, is an inhibitor of EnvM, the enoyl reductase from Escherichia coli. Here we show that triclosan specifically inhibits InhA, the enoyl reductase from Mycobacterium tuberculosis and a target for the antitubercular drug isoniazid. Binding of triclosan to wild-type InhA is uncompetitive with respect to both NADH and trans-2-dodecenoyl-CoA, with Ki‘ values of 0.22 ± 0.02 and 0.21 ± 0.01 μM, respectively. Replacement of Y158, the catalytic tyrosine residue, with Phe, reduces the affinity of triclosan for the enzyme and results in noncompetitive inhibition, with Ki and Ki‘ values of 36 ± 5 and 47 ± 5 μM, respectively. Consequently, the Y158 hydroxyl group is important for triclosan binding, suggesting that triclosan binds in similar ways to both InhA and EnvM. In addition, the M161V and A124V InhA mutants, which result in resistance of Mycobacterium smegmatis to triclosan, show significantly reduced affinity for triclosan. Inhibition of M161V is noncompetitive with Ki‘ = 4.3 ± 0.5 μM and Ki = 4.4 ± 0.9 μM, while inhibition of A124V is uncompetitive with Ki‘ = 0.81 ± 0.11 μM. These data support the hypothesis that the mycobacterial enoyl reductases are targets for triclosan. The M161V and A124V enzymes are also much less sensitive to isoniazid compared to the wild-type enzyme, indicating that triclosan can stimulate the emergence of isoniazid-resistant enoyl reductases. In contrast, I47T and I21V, two InhA mutations that occur in isoniazid-resistant clinical isolates of M. tuberculosis, show unimpaired inhibition by triclosan, with uncompetitive inhibition constants (Ki‘) of 0.18 ± 0.01 and 0.12 ± 0.01 μM, respectively. The latter result indicates that InhA inhibitors targeted at the enoyl substrate binding site may be effective against existing isoniazid-resistant strains of M. tuberculosis.Keywords
This publication has 15 references indexed in Scilit:
- Crystallographic analysis of triclosan bound to enoyl reductaseJournal of Molecular Biology, 1999
- Inhibitor Binding Studies on Enoyl Reductase Reveal Conformational Changes Related to Substrate RecognitionJournal of Biological Chemistry, 1999
- Crystal Structure of the Mycobacterium tuberculosis Enoyl-ACP Reductase, InhA, in Complex with NAD+ and a C16 Fatty Acyl SubstrateJournal of Biological Chemistry, 1999
- Structural basis and mechanism of enoyl reductase inhibition by triclosanJournal of Molecular Biology, 1999
- Modification of the NADH of the Isoniazid Target (InhA) from Mycobacterium tuberculosisScience, 1998
- Susceptibility to levofloxacin of Mycobacterium tuberculosis isolates from patients with HIV-related tuberculosis and characterization of a strain with levofloxacin monoresistanceAIDS, 1997
- MOLECULAR MECHANISMS OF DRUG RESISTANCE IN MYCOBACTERIUM TUBERCULOSISAnnual Review of Biochemistry, 1996
- Studies on the Mechanism of Action of Isoniazid and Ethionamide in the Chemotherapy of TuberculosisJournal of the American Chemical Society, 1995
- The global tuberculosis situation and the new control strategy of the World Health OrganizationTubercle, 1991
- Identification of common molecular subsequencesJournal of Molecular Biology, 1981